期刊文献+

弥漫增生型狼疮肾炎和膜型狼疮肾炎的不同细胞因子表达谱提示不同的免疫学发病机制 被引量:3

Diffuse proliferative lupus nephritis and membranous lupus nephritis: does different serum cytokine profiling suggest different immunological pathogenesis?
原文传递
导出
摘要 目的从系统生物学角度全面研究弥漫增生型狼疮肾炎(Ⅳ型LN)和膜型狼疮肾炎(V型LN)患者血清细胞因子表达谱。方法分离静脉血清,通过抗体芯片技术同时检测4种Th1和5种Th2细胞因子表达。结果①细胞因子表达谱:在检测的9种细胞因子中,Ⅳ型LN患者有7种明显升高,包括3种Th1细胞因子[干扰素(INF)-γ自细胞介素(IL)-2、肿瘤坏死因子(TNF)-α)]和4种Th2细胞因子(IL-4、IL-6、IL-10、IL-13);而V型LN仅有4种细胞因子表达上调(IL-2、IL-4、IL-10和IL-13)。②相关性分析:IV型LN患者细胞因子与临床表现之间相关性较强,如IL-5与抗dsDNA抗体滴度及血肌酐呈正相关、与C3呈负相关;IL-10与系统性红斑狼疮(SLE)疾病活动指数(SLEDAI)呈正相关、与尿蛋白及血红蛋白浓度均呈负相关;IL—13与尿蛋白浓度呈负相关,IL-1与SLEDAI呈正相关、与血红蛋白浓度呈负相关。V型LN患者仅IL-1与血肌酐之间呈正相关,IL-4与尿蛋白之间呈负相关。结论不同病理分型的LN患者体内细胞因子表达谱不同,提示不同病理分型的LN其内在的免疫学发病机制存在差异,也提示不同的细胞因子表达可能代表不同类型的LN。 Objective To obtain a global view of cytokine profile in lupus nephritis (LN), and to compare the pattern of cytokine profile in patients with different renal lesions, primarily diffuse proliferative lupus nephritis (IV-LN) and membranous lupus nephritis (V-LN). Methods Thirtypatients with biopsy proven active LN (class IV, n=15; class V, n=15) and 15 healthy controls were enrolled in this study. Serum concentration of Thl cytokines (IFN-γ, IL-1, IL-2, and TNF-α) and Th2 cytokines (IL-4, IL-5, IL-6, IL-10, IL-13) were simultaneously analyzed using Fast Quant Human Th1/Th2 protein array. Results (1) Cytokine profiling: in patients with class Ⅳ-LN, the levels of most of the detected cytokines elevated marked compared to normal controls, including both Thl (IL-2, INF-γ and TNF-α) and Th2 (IL-4, IL-6, IL-10 and IL-13 ) cytokines. Among them, both Th 1 (INF-γand TNF-α ) and Th2 (IL-6, IL- 10 and IL- 13 ) cytokines were 10 times higher than normal controls. However, patients with class V LN demonstrated a different cytokine profiling compared to class Ⅳ LN. Only 4 out of 9 cytokines were significantly increased. In addition to IL-2, all of those cytokines produced by Th2 (IL-4, IL-10 and IL-13) as well as IL-10 was 10 times higher than normal controls. The main difference of eytokines between patientswith class Ⅳ LN and patients with class V LN was among Thl cytokines (IFN-γ IL-2 and TNF-α). There was a significant correlation between clinical manifestations and eytokines in class Ⅳ LN, especially among Th2 cytokine. There was positive correlation between IL-5 and anti-dsDNA titer(r=0.708, P〈0.05), IL-5 and creatinin(r=0.681, P〈0.05 ) and IL-10 and SLEDAI scores (r=0.877, P〈0.01 ). On the other hand, there was also negative correlation between some Th2 cytokines and clinical manifestations. There was negative correlation between IL-5 and complement C3 level (r=-01643, P〈0.05), IL-10 and proteinuria(r=-0.659, P〈0.05), IL-10 and hemoglobin level (r=-0.856, P〈 0.001 ), as well as IL-13 and proteinuria (r=-0.769, P〈0;05). In addition, IL-1 was positive correlated with SLEDAI, while it was negatively correlated with hemoglobulin level. As for class Ⅴ LN, there was positive correlation between IL-I and creatinin level (r=0.784, P〈0.05), but negative correlation between IL-4 and proteinuria .(r=-0.754, P〈0.05 ). Conclusion Patients with class Ⅳ renal lesion have shown a broad changes of cytokine activity, while up-regulation of Th2 cytokines is more predominant in patients with class Ⅴ LN. These suggest that the expression of different cytokines may be associated with different patterns of lupus renal lesions. These findings may shed light on the further exploring of the underlying mechanisms that mediate different patterns of renal lesions, as well as designing a rational therapeutic strategy for the treatment of LN.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2010年第1期8-12,共5页 Chinese Journal of Rheumatology
关键词 狼疮肾炎 细胞因子类 免疫 Lupus nephritis Cytokines Immunity
  • 相关文献

参考文献15

  • 1姜玉章,季晓辉,李玉峰,苏定雷,李元媛.体外环磷酰胺和环孢素A对系统性红斑狼疮患者细胞因子释放及Th细胞亚群的作用研究[J].中华风湿病学杂志,2006,10(3):161-165. 被引量:6
  • 2Hale MB, Krutzik PO, Samra SS, et al. Stage dependent aberrant regulation of cytokine-STAT signaling in routine systemic lupus erythematosus. PLoS One, 2009, 25: 6756.
  • 3Calvani N, Tucci M, Richards HB, et al. Thl cytokines in the pathogenesis of lupus nephritis: the role of IL-18. Autoimmunity Rev, 2005, 4: 542- 548.
  • 4Cheng S, Hu D, Shi X, et al. The relationship between Th1/Th2 type cells and disease activity in patients with lupus nephritis. Chin Med J (Engl), 2000, 113: 877-880.
  • 5Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982, 25: 1271-1277.
  • 6张榕,王晓非,赵丽娟,肖卫国,姜奕.阻断4-1BB/4-1BBL通路对系统性红斑狼疮T淋巴细胞增殖和细胞因子分泌的影响[J].中华风湿病学杂志,2008,12(4):222-225. 被引量:1
  • 7Wong CK, Ho CY, Li El(, et al. Elevation of proinflammatory eytokine(IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus.Lupus, 2000, 9: 589-593.
  • 8Grondal G, Gunnarsson I, Ronnelid J, et al. Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol, 2000, 18: 565-570.
  • 9Mathian A, Koutouzov S. Interferon-alpha: a key cytokine in systemic lupus erythematosus pathogenesis. Rev Med Interne,2008, 29: 696-700.
  • 10Ripley BJ, Goncalves B, Isenberg DA, et al. Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia. Ann Rheum Dis, 2005, 64: 849-853.

二级参考文献20

  • 1苏定雷,李元媛,王慧娟,宣恒报,郑绍同,李玉峰,季晓辉.霉酚酸对21例系统性红斑狼疮患者细胞因子释放及Th细胞亚群的作用研究[J].南京医科大学学报(自然科学版),2004,24(4):368-370. 被引量:5
  • 2张榕,罗晓光,张晓莉,赵丽娟.系统性红斑狼疮患者CD4^+ T细胞上CD137的表达[J].中国免疫学杂志,2007,23(2):167-169. 被引量:4
  • 3Zheng GX, Wang B, Chen AS. The 4-1BB costimulation augments the proliferation of CD4^+CD25^+ regulatory T cells. J Immunol, 2004, 173: 2428-2434.
  • 4Amit M, Mor A, Weisagarten J, et al. Inactive systemic lupus erythematosus in associated with a normal stimulated Th1/Th2 cytokine secretory pattern. Cytokine, 2000, 12: 1405-1408.
  • 5Funauchi M, Ikoma S, Enomodo H, et al. Decreased Thl-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol, 1998, 27: 219-224.
  • 6Vialland JF, Pellegrin JL, Romchin V, et al. Th1[IL-2, interferon gamma (IFN-gamma)] and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol, 1999, 115: 189- 195.
  • 7Wong CK, Ho CY, Li EK, et al. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentration in patients with systemic lupus erythematosus. Lupus, 2000, 9: 589-593.
  • 8Alderson MR, Smith CA, Tough TW, et al. Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol, 1994, 24: 2219-2227.
  • 9Chu NR, DeBenedette MA, Stiernholm BN, et al. Role of IL-12 and 4-1BB ligand in cytokine production by CD28^+ and CD28- T cell. J Immunol, 1997, 158:3081-3089
  • 10Pohe T, Jagemann A, Foell J, et al. CD137 ligand prevents the development of T-helper type 2 cell-mediated allergic asthma by interferon-gamma-producing CD8^+ T cells. Clin Exp Allergy, 2007, 37:1374-1385.

共引文献5

同被引文献38

  • 1张奉春,周滨,董怡.补体C1q及抗C1q抗体在狼疮肾炎发病机制中的作用[J].中华医学杂志,2005,85(14):955-959. 被引量:18
  • 2周滨,张奉春,董怡.补体C1q及抗C1q抗体与系统性红斑狼疮及狼疮肾炎相关性的研究[J].中华风湿病学杂志,2005,9(12):725-728. 被引量:23
  • 3汪国生,钱龙,张宏,单曙光,杨国俊,王玮,厉小梅,李向培.联合检测C_1q抗体、双链DNA抗体对系统性红斑狼疮的诊断价值[J].中国综合临床,2006,22(5):411-414. 被引量:10
  • 4吴哲,杨贺,李彦科.狼疮性肾炎的治疗进展[J].实用药物与临床,2006,9(4):257-258. 被引量:5
  • 5Steinmetz OM, Velden J, Kneissler U, et al. Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis. Kidney Int, 2008, 74: 448-457.
  • 6Hochberg MC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40: 1725.
  • 7Manzo A, Vitolo B, Humby F, et al. Mature antigen-experienced T helper ceils synthesize and secrete the B cell chemoattraetant CXCL13 in the inflammatory environment of the rheumatoid joint. Arthritis Rheum, 2008, 58: 3377-3387.
  • 8Yu H, Shahsafaei A, Dorfman DM. Germinal-center T-helpercell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma. Am J Clin Pathol, 2009, 131: 33-41.
  • 9Wong CK, Wong PT, Tam LS, et al. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J Clin Immunol, 2010, 30: 45-52.
  • 10Schiffer L, Kampers P, Davalos-Misslitz AM, et al. B-cellattracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). Nephrol Dial Transplant, 2009, 24: 3708-3712.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部